APIS · LAPC
Locally Advanced Pancreatic Cancer: Options When Surgery Is Not Possible
For locally advanced pancreatic cancer (LAPC), chemotherapy usually comes first. If restaging shows no uncontrolled distant spread, a hospital may consider local radiation or reassess surgery. Proton or carbon-ion review depends on treatment response, recovery and the nearby stomach and bowel.
Locally Advanced Disease and Surgery
Locally advanced pancreatic cancer usually means that the tumor involves nearby structures, often major blood vessels, so it cannot be removed at the time of review. It differs from cancer that has spread to distant organs.
After systemic treatment, updated imaging and a pancreatic surgical opinion show whether an operation can now be reconsidered. [1][2]
Local Radiation After Chemotherapy
Restaging after systemic treatment helps the team answer three questions: [1][3]
- Can surgery now be reconsidered?
- Does the disease remain mainly local?
- Have strength, nutrition and organ function recovered enough for further treatment?
Radiation treats a defined area. It does not replace systemic treatment for disease elsewhere in the body. You can request review during chemotherapy so both teams can discuss timing.
Proton and Carbon-Ion Options
Protons can reduce dose beyond the tumor. Carbon ions also have a higher biological effect. The stomach and bowel lie close to the pancreas, which can limit the radiation dose for either treatment.
Conventional radiation, chemoradiation and stereotactic body radiation therapy (SBRT) also remain options. The plan should fit the disease and nearby organs, rather than begin with a preferred machine. [3][4]
Proton and carbon-ion therapy: what differsEvidence and Limitations
A 2025 phase II study treated 49 patients with carbon ions after chemotherapy. Reported 2-year local-regional control was 72.9%, but the study did not meet its primary endpoint for local-regional progression-free survival. These are different measures. [5]
The study excluded gastrointestinal invasion and cannot establish that carbon ions are better than other radiation methods. Bowel or stomach involvement and the patient’s recovery after chemotherapy are central to review.
Required Records for Hospital Review
For review after chemotherapy, the hospital needs the drug names and dates, response scans and any updated surgical opinion. Explain weight loss, nutrition, jaundice, bile-duct stents, pain or recent infection. These details help the team plan timing and supportive care. [1][7]
General records and submission guidance. Korean hospital programs.
Treatment and Travel Planning
Before traveling, make sure you are medically stable enough for the trip and know how ongoing treatment will be handled. Jaundice, infection, dehydration, poor nutrition or uncontrolled symptoms may need local care first.
The hospital determines the current treatment course after review. Preparation and treatment schedules are separate from the total time needed in Korea.
Explore Review for LAPC
Discuss whether local treatment could fit after chemotherapy and restaging.
Sources and dates
- Pan-Asian adapted ESMO Clinical Practice Guidelines for pancreatic cancer (2025). Resectability assessment, systemic therapy, and reassessment of locally advanced disease.
- National Cancer Institute. Pancreatic Cancer Treatment PDQ, health professional version. LAPC options and randomized radiation evidence.
- ASTRO, pancreatic radiation guideline update, August 13, 2026.
- Chuong et al. Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline. Online August 2026. doi:10.1016/j.prro.2026.07.002.
- Zhang et al. Prospective Phase II Clinical Trial of Carbon Ion Radiotherapy Combined with Chemotherapy for Locally Advanced Pancreatic Carcinoma. International Journal of Radiation Oncology Biology Physics, 2025. doi:10.1016/j.ijrobp.2025.06.3881.
- Yonsei Cancer Center, official program update, August 19, 2026.
- National Cancer Institute. Pancreatic Cancer Testing & Diagnosis. Laboratory and molecular testing.
Content reviewed October 23, 2026.
